TGTX - CIK 0001001316
TG THERAPEUTICS, INC. has filed 1,133 documents with the SEC between 1996 and 2026. The most frequent type is insider trade (289 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Quarterly report | 10-Q | 2026-05-06 | 2026-03-31 |
| Major company event | 8-K | 2026-05-06 | 2026-05-06 |
| Proxy statement | DEF 14A | 2026-04-30 | 2026-06-11 |
| SCHEDULE 13G | - | 2026-04-29 | - |
| SCHEDULE 13G/A | - | 2026-03-27 | - |
| Major company event | 8-K | 2026-03-20 | 2026-03-18 |
| Annual report | 10-K | 2026-02-27 | 2025-12-31 |
| Major company event | 8-K | 2026-02-26 | 2026-02-26 |
| Insider trade | 4 | 2026-01-29 | 2026-01-28 |
| Major company event | 8-K | 2026-01-13 | 2026-01-13 |
| Insider trade | 4 | 2026-01-09 | 2026-01-08 |
| Insider trade | 4 | 2026-01-09 | 2026-01-08 |
| Insider trade | 4 | 2025-11-25 | 2025-11-24 |
| Insider sale notice | 144 | 2025-11-24 | - |
| Insider trade | 4 | 2025-11-07 | 2025-11-05 |
| Quarterly report | 10-Q | 2025-11-05 | 2025-09-30 |
| Major company event | 8-K | 2025-11-03 | 2025-11-03 |
| Insider trade | 4 | 2025-09-12 | 2025-09-11 |
| Insider sale notice | 144 | 2025-09-11 | - |
| S-3ASR | - | 2025-08-08 | - |
| Employee stock plan | S-8 | 2025-08-08 | - |
| Quarterly report | 10-Q | 2025-08-08 | 2025-06-30 |
| Major company event | 8-K | 2025-08-04 | 2025-08-04 |
| Insider trade | 4 | 2025-06-16 | 2025-06-12 |
| Insider trade | 4 | 2025-06-16 | 2025-06-12 |
| Insider trade | 4 | 2025-06-16 | 2025-06-12 |
| Insider trade | 4 | 2025-06-16 | 2025-06-12 |
| Insider trade | 4 | 2025-06-16 | 2025-06-12 |
| Insider sale notice | 144 | 2025-06-13 | - |
| Major company event | 8-K | 2025-06-13 | 2025-06-12 |
| Quarterly report | 10-Q | 2025-05-09 | 2025-03-31 |
| Major company event | 8-K | 2025-05-05 | 2025-05-05 |
| SCHEDULE 13G/A | - | 2025-04-30 | - |
| Annual report to shareholders | ARS | 2025-04-30 | 2024-12-31 |
| Proxy materials | DEFA14A | 2025-04-30 | - |
| Proxy statement | DEF 14A | 2025-04-30 | 2025-06-12 |
| PRE 14A | - | 2025-04-18 | 2025-06-12 |
| Insider trade | 4 | 2025-03-18 | 2025-03-17 |
| Insider trade | 4 | 2025-03-11 | 2025-03-10 |
| Annual report | 10-K | 2025-03-03 | 2024-12-31 |
| Major company event | 8-K | 2025-03-03 | 2025-03-03 |
| Insider trade | 4 | 2025-01-30 | 2025-01-29 |
| Insider trade | 4 | 2025-01-30 | 2025-01-29 |
| Major company event | 8-K | 2025-01-14 | 2025-01-14 |
| SCHEDULE 13G/A | - | 2025-01-08 | - |
| Insider trade | 4 | 2025-01-07 | 2025-01-03 |
| Insider sale notice | 144 | 2025-01-06 | - |
| Insider sale notice | 144 | 2025-01-03 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| 144/A | - | 2024-11-12 | - |